ASCO concurs with cancer care ontario for CRC follow-up

ASCO concurs with cancer care ontario for CRC follow-up
The American Society of Clinical Oncology has endorsed Cancer Care Ontario guidelines for colorectal cancer survivor follow-up care, according to a study published online Nov. 12 in the Journal of Clinical Oncology.

(HealthDay)—The American Society of Clinical Oncology (ASCO) has endorsed Cancer Care Ontario (CCO) guidelines for colorectal cancer survivor follow-up care, according to a study published online Nov. 12 in the Journal of Clinical Oncology.

Jeffrey A. Meyerhardt, M.D., M.P.H., from the Dana-Faber Cancer Institute in Boston, and colleagues from an ASCO panel considered endorsement of the CCO Guideline on Follow-up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer.

The ASCO agreed with the CCO recommendations, and recommended endorsement with incorporation of qualifying statements. Surveillance should be guided by the assumed risk of recurrence and patients' functional status. For five years, medical history, physical examination, and carcinoembryonic antigen testing should be conducted every three to six months, with testing recommended in the more frequent range for patients at higher risk of recurrence. In most cases, a computed tomography scan (abdomen and chest) should be performed annually for three years. Outside of a clinical trial, scans should not be used for . One year after the initial surgery and every five years thereafter the patient should undergo surveillance colonoscopy. Colonoscopy should be performed after completion of adjuvant therapy (before one year) if it was not done before diagnosis. Maintenance of a healthy weight and an active lifestyle are recommended for secondary prevention. Surveillance tests should not be performed if the patient is not a candidate for surgery or systemic therapy due to severe comorbid conditions.

"The ASCO Panel concurred with the CCO recommendations and recommended endorsement, with the addition of several qualifying statements," the authors write.

More information: Abstract
Full Text

Related Stories

Adherence to cancer surveillance guidelines varies

date Mar 30, 2012

(HealthDay) -- Insured breast cancer survivors have high rates of guideline-recommended recurrence testing and non-recommended metastatic testing, while only about half of colorectal cancer survivors undergo ...

Overuse of surveillance colonoscopy after resection

date Feb 01, 2013

(HealthDay)—Approximately one-third of patients with normal results on their first and second colonoscopies after undergoing curative resection for colorectal cancer undergo subsequent surveillance colonoscopies ...

SGO issues top five Choosing Wisely recommendations

date Nov 06, 2013

(HealthDay)—The top five gynecologic oncology-related issues that physicians and patients should question have been released by the Society of Gynecologic Oncology (SGO) as part of the Choosing Wisely campai ...

ATS issues top five 'Choosing Wisely' recommendations

date Oct 29, 2013

(HealthDay)—The top five pulmonology-related issues that physicians and patients should question have been released by the American College of Chest Physicians and American Thoracic Society (ATS) as part ...

Recommended for you

Finding liver cancer early and reversing its course

date 6 hours ago

Liver cancer is often lethal in humans because it is diagnosed in late stages, but new work in animal models has identified a potential diagnostic biomarker of the disease and a potential way to reverse the damage done. The ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.